Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-029340
Filing Date
2015-05-11
Accepted
2015-05-11 16:51:54
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v409020_10q.htm 10-Q 342989
2 EXHIBIT 31.1 v409020_ex31-1.htm EX-31.1 8358
3 EXHIBIT 31.2 v409020_ex31-2.htm EX-31.2 8499
4 EXHIBIT 32.1 v409020_ex32-1.htm EX-32.1 4212
5 EXHIBIT 32.2 v409020_ex32-2.htm EX-32.2 4193
6 EXHIBIT 99.1 v409020_ex99-1.htm EX-99.1 128680
  Complete submission text file 0001144204-15-029340.txt   6541899

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fbio-20150331.xml EX-101.INS 977235
8 XBRL TAXONOMY EXTENSION SCHEMA fbio-20150331.xsd EX-101.SCH 54921
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20150331_cal.xml EX-101.CAL 40173
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20150331_def.xml EX-101.DEF 371945
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20150331_lab.xml EX-101.LAB 426594
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20150331_pre.xml EX-101.PRE 416857
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 15851485
SIC: 2834 Pharmaceutical Preparations